Advanced ReGen Medical Technologies, LLC – Trademark Portfolio
Entity Type: 16
Advanced ReGen Medical Technologies, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 7 Nice Classification classes. The owner is based in Houston, TX.
Ste 200
4203 Yoakum
Houston, TX 77006
Showing of trademarks Trademarks
Trademark Classifications
Advanced ReGen Medical Technologies, LLC's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Advanced ReGen Medical Technologies, LLC have?
Advanced ReGen Medical Technologies, LLC has 4 U.S. trademarks filed with the USPTO.
What trademark classes does Advanced ReGen Medical Technologies, LLC file in?
Advanced ReGen Medical Technologies, LLC files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Advanced ReGen Medical Technologies, LLC's trademark registration success rate?
Advanced ReGen Medical Technologies, LLC has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.